Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

699

Figures (1-2)

Tables (1-3)

Sum=855

Publishing Process of This Article

Item

Count

Browse

Download

Sum=118

Nov 15, 2024 (publication date) through Dec 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4468-4476
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4468

Table 3 The effect of invigorating-spleen and anticancer prescription on tumor inhibition rate of mice

^aP < 0.05 compared to the control group.

^bP < 0.05 compared to the low-dose group of invigorating-spleen and anticancer prescription.

ISAP: Invigorating-spleen and anticancer prescription.

Citation: Wang W, Wang J, Ren XX, Yue HL, Li Z. Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model. World J Gastrointest Oncol 2024; 16(11): 4468-4476
URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4468.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4468